BioSpace News Archive

Healthcare providers to benefit from significantly improved access to the clinically superior POWERWAND, shown to reduce CLABSIs and the overall cost of care

Industry veteran brings extensive financial and public biotechnology company experience

Final study results accepted for “Late Breaking Presentation” on October 16, 2019

Glympse Bio, Inc., a life science company developing in vivo activity sensors to transform disease detection, monitoring and drug response, announced today that Francis Cuss has been appointed to its Board of Directors

Trillium Community Health Plan has awarded grants totaling $1.2M to seven organizations from its 2019 Innovation fund.

This motto will hold true when the Arthroscopy Association of North America (AANA) and the Society of Military Orthopaedic Surgeons (SOMOS) hold their 10th Annual AANA/SOMOS Lab Course August 2-4 at the Orthopaedic Learning Center (OLC) in Rosemont, Illinois.

Therap provides comprehensive tools to improve quality of service, client outcomes, and accountability within Long-Term Services & Supports (LTSS) programs.

Scientists have taken a major step closer to being able to 3D bioprint functional organs, after researchers devised a method of rebuilding components of the human heart, according to a study published in the August 2nd edition of Science.

As part of its partnership with Mayo Clinic in the development of a Limb Loss and Preservation Registry for the National Institute of Child Health and Human Development, the Thought Leadership & Innovation Foundation supported the Mayo Clinic participation at the Amputee Coalition’s 2019 National Conference in San Antonio, Texas.

A team of researchers from Carnegie Mellon University has published a paper in Science that details a new technique allowing anyone to 3D bioprint tissue scaffolds out of collagen, the major structural protein in the human body.